Oppenheimer Maintains Outperform on Ecolab (ECL)

Oppenheimer is out with its report today on Ecolab ECL, maintaining Overweight. In a note to clients, Oppenheimer writes, "ECL is a compelling growth investment, in our opinion, with a dominant franchise that normally doubles EPS every five years, generates high 20%+ returns, and is still in the early stages of its market opportunity. ECL has only $6B of a highly fragmented $51B global addressable market; its unique business model based on high-touch services is a powerful competitive advantage and, in our opinion, can triple revenue by cross-selling its portfolio. Near term, while ECL has less leverage to a recovery since it grew earnings during the recession, it consistently generates above-GDP growth throughout the cycle and typically outperforms." Oppenheimer has a $56 PT on ECL. At the time of posting, shares of ECL were trading at $49.55, down 0.20% from Thursday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsEcolabMaterialsOppenheimerSpecialty Chemicals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!